Since the appearance of the COVID-19 pandemic (at the end of 2019, Wuhan, China), the recognition of COVID-19 with medical imaging has become an active research topic for the machine learning and computer vision community. This paper is based on the results obtained from the 2021 COVID-19 SPGC challenge, which aims to classify volumetric CT scans into normal, COVID-19, or community-acquired pneumonia (Cap) classes. To this end, we proposed a deep-learning-based approach (CNR-IEMN) that consists of two main stages. In the first stage, we trained four deep learning architectures with a multi-tasks strategy for slice-level classification. In the second stage, we used the previously trained models with an XG-boost classifier to classify the whole CT scan into normal, COVID-19, or Cap classes. Our approach achieved a good result on the validation set, with an overall accuracy of 87.75% and 96.36%, 52.63%, and 95.83% sensitivities for COVID-19, Cap, and normal, respectively. On the other hand, our approach achieved fifth place on the three test datasets of SPGC in the COVID-19 challenge, where our approach achieved the best result for COVID-19 sensitivity. In addition, our approach achieved second place on two of the three testing sets.
The recognition of Covid-19 infection and distinguishing it from other Lung diseases from CT-scan is an emerging field in machine learning and computer vision community. In this paper, we proposed deep learning based approach to recognize the Covid-19 infection from the CT-scans. Our approach consists of two main stages. In the first stage, we trained deep learning architectures with Multi-task strategy for Slice-Level classification. In the second stage, we used the previous trained models with XG-boost classifier to classify the whole CT-scan into Normal, Covid-19 or Cap class. The evaluation of our approach achieved promising results on the validation data of SPGC-COVID dataset. In more details, our approach achieved 87.75% as overall accuracy and 96.36%, 52.63% and 95.83% sensitivities for Covid-19, Cap and Normal, respectively. From other hand, our approach achieved the fifth place on the three test datasets of SPGC on COVID-19 challenge where our approach achieved the best result for Covid-19 sensitivity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.